109 related articles for article (PubMed ID: 8908497)
1. Gene therapy for prostate cancer.
Hrouda D; Dalgleish AG
Gene Ther; 1996 Oct; 3(10):845-52. PubMed ID: 8908497
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy for prostate cancer.
Hrouda D; Perry M; Dalgleish AG
Semin Oncol; 1999 Aug; 26(4):455-71. PubMed ID: 10482188
[TBL] [Abstract][Full Text] [Related]
3. Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer.
Simons JW; Mikhak B; Chang JF; DeMarzo AM; Carducci MA; Lim M; Weber CE; Baccala AA; Goemann MA; Clift SM; Ando DG; Levitsky HI; Cohen LK; Sanda MG; Mulligan RC; Partin AW; Carter HB; Piantadosi S; Marshall FF; Nelson WG
Cancer Res; 1999 Oct; 59(20):5160-8. PubMed ID: 10537292
[TBL] [Abstract][Full Text] [Related]
4. Current status of experimental therapeutics for prostate cancer.
Moon C; Park JC; Chae YK; Yun JH; Kim S
Cancer Lett; 2008 Aug; 266(2):116-34. PubMed ID: 18440696
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte-macrophage colony-stimulating factor-transduced allogeneic cancer cellular immunotherapy: the GVAX vaccine for prostate cancer.
Simons JW; Sacks N
Urol Oncol; 2006; 24(5):419-24. PubMed ID: 16962494
[TBL] [Abstract][Full Text] [Related]
6. New prospectives of prostate cancer gene therapy: molecular targets and animal models.
Hsieh CL; Chung LW
Crit Rev Eukaryot Gene Expr; 2001; 11(1-3):77-120. PubMed ID: 11693967
[TBL] [Abstract][Full Text] [Related]
7. New molecular targets in advanced prostate cancer.
Dawson NA
Expert Rev Anticancer Ther; 2006 Jul; 6(7):993-1002. PubMed ID: 16831072
[TBL] [Abstract][Full Text] [Related]
8. Emerging concepts in GM-CSF gene-transduced tumor vaccines for human prostate cancer.
Lim M; Simons JW
Curr Opin Mol Ther; 1999 Feb; 1(1):64-71. PubMed ID: 11249686
[No Abstract] [Full Text] [Related]
9. Immunological approaches for the treatment of prostate cancer.
Slovin SF; Kelly WK; Scher HI
Semin Urol Oncol; 1998 Feb; 16(1):53-9. PubMed ID: 9508084
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy of murine prostate cancer using whole tumour cells killed ex vivo by cytosine deaminase/5-fluorocytosine suicide-gene therapy.
Pandha HS; Cook D; Greenhalgh R; Dalgleish A
BJU Int; 2005 Jun; 95(9):1336-43. PubMed ID: 15892827
[TBL] [Abstract][Full Text] [Related]
11. Treatment of biochemical recurrence of prostate cancer with granulocyte-macrophage colony-stimulating factor secreting, allogeneic, cellular immunotherapy.
Urba WJ; Nemunaitis J; Marshall F; Smith DC; Hege KM; Ma J; Nguyen M; Small EJ
J Urol; 2008 Nov; 180(5):2011-7; discussion 2017-8. PubMed ID: 18801509
[TBL] [Abstract][Full Text] [Related]
12. Ex-vivo gene therapy using cytokine-transduced tumor vaccines: molecular and clinical pharmacology.
Simons JW; Mikhak B
Semin Oncol; 1998 Dec; 25(6):661-76. PubMed ID: 9865681
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer gene therapy: outcome of basic research and clinical trials.
Nasu Y; Djavan B; Marberger M; Kumon H
Tech Urol; 1999 Dec; 5(4):185-90. PubMed ID: 10591255
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cell-based treatment of cancer: closing in on a cellular therapy.
Valone FH; Small E; MacKenzie M; Burch P; Lacy M; Peshwa MV; Laus R
Cancer J; 2001; 7 Suppl 2():S53-61. PubMed ID: 11777265
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy for prostate cancer.
Tangney M; Ahmad S; Collins SA; O'Sullivan GC
Postgrad Med; 2010 May; 122(3):166-80. PubMed ID: 20463426
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer immunotherapy.
McNeel DG
Curr Opin Urol; 2007 May; 17(3):175-81. PubMed ID: 17414515
[TBL] [Abstract][Full Text] [Related]
17. Different approaches of gene therapy used in prostate cancer.
Ghosh A
Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(1):103-11. PubMed ID: 16171569
[TBL] [Abstract][Full Text] [Related]
18. Bioactivity of human GM-CSF gene therapy in metastatic renal cell carcinoma and prostate cancer.
Simons JW
Hinyokika Kiyo; 1997 Nov; 43(11):821-2. PubMed ID: 9436029
[No Abstract] [Full Text] [Related]
19. Phase I/II trial of an allogeneic cellular immunotherapy in hormone-naïve prostate cancer.
Simons JW; Carducci MA; Mikhak B; Lim M; Biedrzycki B; Borellini F; Clift SM; Hege KM; Ando DG; Piantadosi S; Mulligan R; Nelson WG
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3394-401. PubMed ID: 16740763
[TBL] [Abstract][Full Text] [Related]
20. Biological principles and clinical development of prostate cancer gene therapy.
Sanda MG
Semin Urol Oncol; 1997 Feb; 15(1):43-55. PubMed ID: 9050139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
